Genaissance Pharmaceuticals and AstraZeneca sign a genomics agreement

被引：0

|

作者：

不详

机构：

来源：

PHARMACOGENOMICS | 2002年 / 3卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：4 / 4

页数：1

相关论文

共 50 条

[1] Genaissance and AstraZeneca sign pharmacogenomics based agreement
不详
[J]. PHARMACOGENOMICS, 2003, 4 (06) : 693 - 693
[2] AstraZeneca, Ethris sign mRNA agreement
Jarvis, Lisa
[J]. CHEMICAL & ENGINEERING NEWS, 2017, 95 (34) : 15 - 15
[3] Genaissance Pharmaceuticals, Inc.
Oestreicher, P
[J]. PHARMACOGENOMICS, 2002, 3 (02) : 273 - 279
[4] Genaissance Pharmaceuticals to merge with Clinical Data
不详
[J]. PHARMACOGENOMICS, 2005, 6 (05) : 459 - 459
[5] AstraZeneca pushes into genomics
Mccoy, Michael
[J]. CHEMICAL & ENGINEERING NEWS, 2016, 94 (17) : 15 - 15
[6] Genaissance Pharmaceuticals - Focused on niche in evolving arena of pharmacogenomics
Davidson, B
[J]. GENETIC ENGINEERING NEWS, 1998, 18 (15): : 41 - +
[7] Merrion and Rebel Pharmaceuticals Sign Drug Feasibility and Option Agreement
不详
[J]. BIOPHARM INTERNATIONAL, 2011, 24 (01) : 13 - 13
[8] AstraZeneca will acquire Omthera Pharmaceuticals
不详
[J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (03) : 342 - 342
[9] AstraZeneca Pharmaceuticals launches in Zambia
不详
[J]. CARDIOVASCULAR JOURNAL OF AFRICA, 2014, 25 (03) : 142 - 142
[10] AstraZeneca nabs genomics giants
不详
[J]. NATURE BIOTECHNOLOGY, 2016, 34 (06) : 583 - 583

← 1 2 3 4 5 →